JPET Introducing ALZET?ew Model 2006 Pump

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Min, J.-Y.
Right arrow Articles by Simon, R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Min, J.-Y.
Right arrow Articles by Simon, R.

Vol. 291, Issue 3, 1038-1044, December 1999

Differential Effects of Mibefradil, Verapamil, and Amlodipine on Myocardial Function and Intracellular Ca2+ Handling in Rats with Chronic Myocardial Infarction

Jiang-Yong Min, Steffen Sandmann, Achim Meissner, Thomas Unger and Ruediger Simon

Department of Cardiology (J.-Y.M., A.M., R.S.), Institute of Pharmacology (S.S., T.U.), University of Kiel, Germany

Mibefradil is a selective T-type Ca2+ channel blocker that exerts a potent vasodilating but weak inotropic action. The present study compared mibefradil with traditional L-type Ca2+ channel blockers in regard to the effects of chronic oral administration on hemodynamics, contractility, and intracellular Ca2+ handling in failing myocardium from postinfarction rats. Male Wistar rats with ligation-induced myocardial infarction were assigned to placebo or treatment with mibefradil (10 mg/kg/day), verapamil (8 mg/kg/day), or amlodipine (4 mg/kg/day) by oral gavage starting 7 days before the induction of myocardial infarction. Six weeks after myocardial infarction, hemodynamic measurements were performed in conscious animals. In addition, isometric force and free [Ca2+]i were determined in isolated left ventricular papillary muscles. Placebo-treated rats exhibited a decreased mean atrial pressure, an increased left ventricular end-diastolic pressure, and a reduced rate of pressure rise compared with sham-operated animals. Mibefradil treatment significantly improved all of these parameters, whereas both amlodipine and verapamil exerted only minor effects. beta -Adrenergic stimulation with isoproterenol (ISO) enhanced contractility and Ca2+ availability in papillary muscles from sham-operated rats, whereas the ISO-induced inotropic effect in muscles from placebo-treated rats was severely blunted. Chronic mibefradil treatment significantly improved the inotropic response to ISO stimulation, although the Ca2+i availability appeared to be less than in muscles from placebo-treated animals. In contrast, both verapamil and amlodipine did not restore the inotropic and Ca2+i modulating effect of ISO in remodeled myocardium. Thus, T-type Ca2+ current appears to be of pathophysiological relevance in postischemic reperfused myocardium.


0022-3565/99/2913-1038$03.00/0
THE JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
Copyright © 1999 by The American Society for Pharmacology and Experimental Therapeutics



This article has been cited by other articles:


Home page
J. Thorac. Cardiovasc. Surg.Home page
X. Hu, S. P. Yu, J. L. Fraser, Z. Lu, M. E. Ogle, J.-A. Wang, and L. Wei
Transplantation of hypoxia-preconditioned mesenchymal stem cells improves infarcted heart function via enhanced survival of implanted cells and angiogenesis.
J. Thorac. Cardiovasc. Surg., April 1, 2008; 135(4): 799 - 808.
[Abstract] [Full Text] [PDF]


Home page
Eur. J. Cardiothorac. Surg.Home page
X. Hu, J. Wang, J. Chen, R. Luo, A. He, X. Xie, and J. Li
Optimal temporal delivery of bone marrow mesenchymal stem cells in rats with myocardial infarction
Eur. J. Cardiothorac. Surg., March 1, 2007; 31(3): 438 - 443.
[Abstract] [Full Text] [PDF]


Home page
J. Thorac. Cardiovasc. Surg.Home page
J.-Y. Min, Y. Yang, M. F. Sullivan, Q. Ke, K. L. Converso, Y. Chen, J. P. Morgan, and Y.-F. Xiao
Long-term improvement of cardiac function in rats after infarction by transplantation of embryonic stem cells
J. Thorac. Cardiovasc. Surg., February 1, 2003; 125(2): 361 - 369.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
J.-Y. Min, M. F. Sullivan, X. Yan, X. Feng, V. Chu, J.-F. Wang, I. Amende, J. P. Morgan, K. D. Philipson, and T. G. Hampton
Overexpression of Na+/Ca2+ exchanger gene attenuates postinfarction myocardial dysfunction
Am J Physiol Heart Circ Physiol, December 1, 2002; 283(6): H2466 - H2471.
[Abstract] [Full Text] [PDF]


Home page
J. Appl. Physiol.Home page
J.-Y. Min, Y. Yang, K. L. Converso, L. Liu, Q. Huang, J. P. Morgan, and Y.-F. Xiao
Transplantation of embryonic stem cells improves cardiac function in postinfarcted rats
J Appl Physiol, January 1, 2002; 92(1): 288 - 296.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 1999 by the American Society for Pharmacology and Experimental Therapeutics.